The effect of AKT inhibition in α-synuclein-dependent neurodegeneration
Parkinson’s disease (PD) is a progressive neurodegenerative disorder affecting millions of individuals worldwide. A hallmark of PD pathology is the accumulation of α-synuclein (α-Syn), a small protein known to support neuronal development and function. However, in PD, α-Syn cumulatively misfolds int...
Saved in:
Main Authors: | Bedri Ranxhi, Zoya R. Bangash, Zachary M. Chbihi, Sokol V. Todi, Peter A. LeWitt, Wei-Ling Tsou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Molecular Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2025.1524044/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alpha-synuclein pathology enhances peripheral and CNS immune responses to bacterial endotoxins
by: Anna-Sophia Hartke, et al.
Published: (2025-02-01) -
Project for a Sculpture
by: Sol LeWitt
Published: (2018-06-01) -
Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies
by: Oliver C. Kiersnowski, et al.
Published: (2025-02-01) -
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity
by: Daniel Torrente, et al.
Published: (2025-01-01) -
Alpha synuclein and inflammaging
by: Geneviève L. Putnam, et al.
Published: (2025-01-01)